Retrovirus vectors

Contributions to Nephrology

Volumn 159, Issue , 2008, Pages 30-46

  Lech, P ^b   Somia, N ^a  

^a Minnesota Medical School Minneapolis   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; INTEGRASE; VIRUS RECEPTOR;

BACTERIOPHAGE P1; GENE THERAPY; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY DISEASE; LENTIVIRINAE; METHODOLOGY; PHYSIOLOGY; PROVIRUS; RETROVIRUS; REVIEW;

BACTERIOPHAGE P1; GENE THERAPY; GENETIC VECTORS; HUMANS; INTEGRASES; KIDNEY DISEASES; LENTIVIRUS; PROVIRUSES; RECEPTORS, VIRUS; RETROVIRIDAE;

EID: 48549096125     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000125574     Document Type: Review

References (51)

1. Weiss RA: Retrovirus classification and cell interactions. J Antimicrob Chemother 1996;37(suppl B):1-11.
2. Greatorex J: The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology 2004;1:22.
3. Overbaugh J, Miller AD, Eiden MV: Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev 2001;65:371-389, table of contents.
4. Cronin J, Zhang XY, Reiser J: Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005;5:387-398.
5. Kielian M, Jungerwirth S: Mechanisms of enveloped virus entry into cells. Mol Biol Med 1990;7:17-31.
6. Barnard RJ, Elleder D, Young JA: Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion. Virology 2006;344:25-29.
7. McDonald D, Vodicka MA, Lucero G, et al: Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002;159:441-452. Epub 2002 Nov 4.
8. Yamashita M, Emerman M: Retroviral infection of non-dividing cells: old and new perspectives. Virology 2006;344:88-93.
9. Shun MC, Raghavendra NK, Vandegraaff N, et al: LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 2007;21:1767-1778.
10. Suzuki Y, Craigie R: The road to chromatin - nuclear entry of retroviruses. Nat Rev Microbiol 2007;5:187-196.
11. Bushman F, Lewinski M, Ciuffi A, et al: Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 2005;3:848-858.
12. Morita E, Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol 2004;20:395-425.
13. Adamson CS, Freed EO: Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol 2007;55:347-387.
14. Naldini L, Blomer U, Gallay P, et al: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
15. Poeschla E, Gilbert J, Li X, Huang S, Ho A, Wong-Staal F: Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol 1998;72:6527-6536.
16. Schnell T, Foley P, Wirth M, Munch J, Uberla K: Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther 2000;11: 439-447.
17. Poeschla EM, Wong-Staal F, Looney DJ: Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998;4:354-357.
18. Olsen JC: Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 1998;5:1481-1487.
19. Rulli SJ Jr, Hibbert CS, Mirro J, Pederson T, Biswal S, Rein A: Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol 2007;81:6623-6631. Epub 2007 Mar 28.
20. Kappes JC, Wu X: Safety considerations in vector development. Somat Cell Mol Genet 2001;26:147-158.
21. Koldej R, Cmielewski P, Stocker A, Parsons DW, Anson DS: Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J Gene Med 2005;7:1390-1399.
22. Brady J, Kashanchi F: Tat gets the 'green' light on transcription initiation. Retrovirology 2005;2:69.
23. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM: Development of a self-inactivating lentivirus vector. J Virol 1998;72:8150-8157.
24. Cullen BR: Nuclear mRNA export: insights from virology. Trends Biochem Sci 2003;28:419-424.
25. Anson DS, Fuller M: Rational development of a HIV-1 gene therapy vector. J Gene Med 2003;5:829-838.
26. Coffin JM: Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol 1979;42:1-26.
27. Hindmarsh P, Leis J: Retroviral DNA integration. Microbiol Mol Biol Rev 1999;63:836-843, table of contents.
28. Wilhelm M, Wilhelm FX: Reverse transcription of retroviruses and LTR retrotransposons. Cell Mol Life Sci 2001;58:1246-1262.
29. Telesnitsky A, Goff SP: Reverse Transcriptase and the Generation of retroviral DNA; in Coffin JM, Hughes SH, Varmus HE (eds): Retroviruses. New York, Cold Spring Harbor Laboratory Press, 1997, pp 121-160.
30. Yu SF, von Ruden T, Kantoff PW, et al: Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 1986;83:3194-3198.
31. Zhu Y, Feuer G, Day SL, Wrzesinski S, Planelles V: Multigene lentiviral vectors based on differential splicing and translational control. Mol Ther 2001;4:375-382.
32. Davies MV, Kaufman RJ: The sequence context of the initiation codon in the encephalomyocarditis virus leader modulates efficiency of internal translation initiation. J Virol 1992;66:1924-1932.
33. Gossen M, Bujard H: Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 2002;36:153-173. Epub 2002 Jun 11.
34. Kafri T, van Praag H, Gage FH, Verma IM: Lentiviral vectors: regulated gene expression. Mol Ther 2000;1:516-521.
35. Gopaul DN, Duyne GD: Structure and mechanism in site-specific recombination. Curr Opin Struct Biol 1999;9:14-20.
36. Choulika A, Guyot V, Nicolas JF: Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J Virol 1996;70:1792-1798.
37. Russ AP, Friedel C, Grez M, von Melchner H: Self-deleting retrovirus vectors for gene therapy. J Virol 1996;70:4927-4932.
38. Latta-Mahieu M, Rolland M, Caillet C, et al: Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum Gene Ther 2002;13:1611-1620.
39. Gusella GL, Fedorova E, Hanss B, Marras D, Klotman ME, Klotman PE: Lentiviral gene transduction of kidney. Hum Gene Ther 2002;13:407-414.
40. Stein CS, Martins I, Davidson BL: The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain. Mol Ther 2005;11:382-389.
41. Miletic H, Fischer YH, Neumann H, et al: Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 2004;15:1091-1100.
42. Kang Y, Stein CS, Heth JA, et al: In vivo gene transfer using a nonprimate lentiviral vector pseudo-typed with Ross River Virus glycoproteins. J Virol 2002;76:9378-9388.
43. Azzouz M, Ralph GS, Storkebaum E, et al: VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004;429:413-417.
44. Mazarakis ND, Azzouz M, Rohll JB, et al: Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001;10:2109-2121.
45. Watson DJ, Kobinger GP, Passini MA, Wilson JM, Wolfe JH: Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 2002;5:528-537.
46. Paulsson M: Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 1992;27:93-127.
47. Heikkila P, Tibell A, Morita T, et al: Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 2001;8:882-890.
48. Lai LW, Chan DM, Erickson RP, Hsu SJ, Lien YH: Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J Clin Invest 1998;101:1320-1325.
49. Choi YK, Kim YJ, Park HS, et al: Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 2003;10:559-568.
50. Oh TK, Quan GH, Kim HY, Park F, Kim ST: Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene. Am J Nephrol 2006;26:326-334. Epub 2006 Jul 5.
51. Binley K, Askham Z, Iqball S, et al: Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 2002;100:2406-2413.